Clinical trial NCT05072756: Opinion of Brazilian Gynecologists on Hormone Therapy for Menopause and Prescriptive Habits
Official title: Opinion of Brazilian Gynecologists on Hormone Therapy for Menopause and Prescriptive
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Menopause
Opinions
Hormone Replacement Therapy
Lead sponsor: Faculdade de Medicina do ABC
Sponsor class: OTHER
First posted: 2021-10-11
Enrollment: 1339
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: CASE_ONLY
Time perspective: CROSS_SECTIONAL
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Active Brazilian licensed gynecologist doctors who see patients

Brief summary: To evaluate Brazilian gynecologists, through structured online questionnaires, with questions directed to their opinions and prescriptive habits about menopause hormone therapy. Research participants will complete the questionnaires in digital format online.

Detailed description: There are few Brazilian population studies on the opinion of Brazilian gynecologists about the hormonal therapy of menopause in climacteric women, their prescriptive habits and their views on the availability of treatments offered, demanding better evaluation and justifying efforts to analyze the perception of professionals in this area in our country.

Methods: To assess gynecologists across the country, through structured online questionnaires, with questions aimed at knowing their opinions and prescriptive habits about menopause hormone therapy. Research participants will complete the questionnaires in digital format online. Doctors will be invited to participate by e-mail messages and by social media.

Eligibility criteria: Inclusion Criteria:

* Brazilian licensed gynecologist doctors

Exclusion Criteria:

* Retired doctors
* Health professionals other than medicine doctor
* Medical specialties other than Gynecology
* Medical employees of the pharmaceutical industry

Primary outcomes:
measure: Prescription preference
timeFrame: At Day 1
Secondary outcomes:
measure: Knowledge of window of opportunity for hormone replacement therapy
timeFrame: At Day 1
measure: Knowledge of indications and contraindications of hormone replacement therapy
timeFrame: At Day 1
Other outcomes:
Locations:
city: São Bernardo do Campo
country: Brazil
facility: Centro de Atenção Integral à Saúde da Mulher
state: SP
Study officials:
affiliation: Faculdade de Medicina do ABC
name: Luciano M Pompei
role: PRINCIPAL_INVESTIGATOR
References:
citation: Taylor HS, Kagan R, Altomare CJ, Cort S, Bushmakin AG, Abraham L. Knowledge of clinical trials regarding hormone therapy and likelihood of prescribing hormone therapy. Menopause. 2017 Jan;24(1):27-34. doi: 10.1097/GME.0000000000000711.
citation: Buhling KJ, von Studnitz FS, Jantke A, Eulenburg C, Mueck AO. Use of hormone therapy by female gynecologists and female partners of male gynecologists in Germany 8 years after the Women's Health Initiative study: results of a survey. Menopause. 2012 Oct;19(10):1088-91. doi: 10.1097/gme.0b013e318250bfda.
citation: Yeganeh L, Boyle J, Teede H, Vincent A. Knowledge and attitudes of health professionals regarding menopausal hormone therapies. Climacteric. 2017 Aug;20(4):348-355. doi: 10.1080/13697137.2017.1304906. Epub 2017 Apr 5.